A randomized, pragmatic, open-label, multicenter phase III trial to evaluate the efficacy and safety of different durations of antimicrobial treatment for osteosynthesis material-associated infections after long bone fracture (DURATIOM)

CLINICAL TRIAL WITH MEDICINES